• Users Online: 499
  • Print this page
  • Email this page

  Article Access Statistics

Year : 2013 | Volume:  57 | Issue Number:  1 | Page:  46-51

CLINICAL INVESTIGATION

Introduction of sugammadex as standard reversal agent: Impact on the incidence of residual neuromuscular blockade and postoperative patient outcome
Ledowski Thomas, Hillyard Samuel, O«SQ»Dea Brendan, Archer Rob, Vilas-Boas Filipe, Kyle Barney

Number of times this article was viewed 4707
Number of times this article has been printed  from the site 131
Number of times this article was emailed to others 2
Remarks given by readers [ Read ] 0

 

 Back To Article